"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

This Practice Point commentary discusses the paper by Dhar and colleagues, which compared outcomes between two cohorts of patients with muscle-invasive bladder cancer who received either 'limited' ...

Expert Rev Anticancer Ther. 2013;13(11):1281-1295. The extended template comprises the standard package with the addition of presacral area, the proximal common iliac and aortic bifurcation. The ...

Analysis of the results of intravesical perfusion therapy combined with immediate or non-immediate hematoporphyrin intravesical perfusion photodynamic therapy (PDT) after TURBT for NMIBC. This is an ...

Effectiveness and safety of first-line atezolizumab in locally advanced or metastatic urothelial cancer: The IMFLAME study. This is an ASCO Meeting Abstract from the 2025 ASCO Genitourinary Cancers ...

Investigators proposed that lymph node dissection should be included as part of radical cystectomy for patients with NMIBC. Lymph node dissection during radical cystectomy (RC) may improve oncologic ...

Fluorescent imaging of indocyanine green (ICG) injection site and its flow in lower limb lymph nodes. (A) Injection site located 2 cm above the inner neck of the lower limb. (B) Injection site in the ...

Using real-world data, a team of U.S.-based investigators analyzed survival outcomes among an independent cohort of patients with metastatic urothelial cancer (UC) treated with immune checkpoint ...

Extended dissection did not improve recurrence-free or overall survival, but it may have a bladder cancer-specific survival benefit possibly because it removes micrometastases. Extended lymph node ...